EA200001078A1 - НОВЫЕ СОЕДИНЕНИЯ 12,13-(ПИРАНОЗИЛ)-ИНДОЛО[2,3-α]ПИРРОЛО[3,4-С]КАРБАЗОЛА И 12,13-(ПИРАНОЗИЛ)-ФУРО[3,4-C]ИНДОЛО[2,3-α]КАРБАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ - Google Patents
НОВЫЕ СОЕДИНЕНИЯ 12,13-(ПИРАНОЗИЛ)-ИНДОЛО[2,3-α]ПИРРОЛО[3,4-С]КАРБАЗОЛА И 12,13-(ПИРАНОЗИЛ)-ФУРО[3,4-C]ИНДОЛО[2,3-α]КАРБАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХInfo
- Publication number
- EA200001078A1 EA200001078A1 EA200001078A EA200001078A EA200001078A1 EA 200001078 A1 EA200001078 A1 EA 200001078A1 EA 200001078 A EA200001078 A EA 200001078A EA 200001078 A EA200001078 A EA 200001078A EA 200001078 A1 EA200001078 A1 EA 200001078A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- indolo
- hydrogen atom
- group
- piranozil
- piranosil
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 title 2
- GZSUIHUAFPHZSU-UHFFFAOYSA-N 9-ethyl-2,3-dihydro-1h-carbazol-4-one Chemical compound C12=CC=CC=C2N(CC)C2=C1C(=O)CCC2 GZSUIHUAFPHZSU-UHFFFAOYSA-N 0.000 title 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- -1 hydroxy, mercapto Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Abstract
Соединения формулы (I)где Rи R, которые могут быть одинаковыми или различными, представляют собой группу формулы U-V, где U представляет одинарную связь или алкиленовую цепь, которая необязательно замещена и/или является ненасыщенной, и V имеет значение, определенное в описании,G представляет атом кислорода или NRгруппу, где Rтакой, как определено в описании,X представляет атом водорода, гидрокси, меркапто или алкилтиогруппу, Y представляет атом водорода, или X+Y представляет карбонильную группу,Xпредставляет атом водорода, гидрокси, алкокси, меркапто или алкилтиогруппу, Yпредставляет атом водорода или X+Yпредставляют карбонильную группу,R, Rи Rтакие, как определено в описании, их изомеры, и соли присоединения их с фармацевтически приемлемой кислотой или основанием. Лекарственные средства.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9914433A FR2801054B1 (fr) | 1999-11-17 | 1999-11-17 | Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200001078A1 true EA200001078A1 (ru) | 2001-06-25 |
EA004737B1 EA004737B1 (ru) | 2004-08-26 |
Family
ID=9552202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200001078A EA004737B1 (ru) | 1999-11-17 | 2000-11-16 | ПРОИЗВОДНЫЕ 12,13-(ПИРАНОЗИЛ)-ИНДОЛО[2,3-α]ПИРРОЛО[3,4-c]КАРБАЗОЛА И 12,13-(ПИРАНОЗИЛ)-ФУРО[3,4-c]ИНДОЛО[2,3-α]КАРБАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ |
Country Status (23)
Country | Link |
---|---|
US (1) | US6569858B2 (ru) |
EP (1) | EP1101770B1 (ru) |
JP (1) | JP3602050B2 (ru) |
KR (1) | KR100453980B1 (ru) |
CN (1) | CN1152040C (ru) |
AT (1) | ATE237625T1 (ru) |
AU (1) | AU771584B2 (ru) |
BR (1) | BR0005426A (ru) |
CA (1) | CA2325779C (ru) |
DE (1) | DE60002142T2 (ru) |
DK (1) | DK1101770T3 (ru) |
EA (1) | EA004737B1 (ru) |
ES (1) | ES2197061T3 (ru) |
FR (1) | FR2801054B1 (ru) |
HK (1) | HK1036991A1 (ru) |
HU (1) | HUP0004574A3 (ru) |
MX (1) | MXPA00010899A (ru) |
NO (1) | NO20005796L (ru) |
NZ (1) | NZ508231A (ru) |
PL (1) | PL343879A1 (ru) |
PT (1) | PT1101770E (ru) |
SI (1) | SI1101770T1 (ru) |
ZA (1) | ZA200006729B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610727B2 (en) | 2000-10-06 | 2003-08-26 | Bristol-Myers Squibb Company | Anhydro sugar derivatives of indolocarbazoles |
US6677450B2 (en) * | 2000-10-06 | 2004-01-13 | Bristol-Myers Squibb Company | Topoisomerase inhibitors |
US6653290B2 (en) | 2000-10-06 | 2003-11-25 | Bristol-Myers Squibb Company | Tumor proliferation inhibitors |
CN1509335A (zh) | 2001-03-22 | 2004-06-30 | ����˹�ж�-����˹˹������˾ | 吲哚并吡咯并咔唑的拓扑异构酶i选择性细胞毒素糖衍生物 |
FR2826653B1 (fr) | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2831169B1 (fr) * | 2001-10-22 | 2003-12-12 | Servier Lab | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ES2326459B1 (es) * | 2008-04-08 | 2010-05-28 | Universidad De Oviedo | Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos. |
CN104031052B (zh) * | 2014-05-20 | 2016-06-08 | 中国科学院南海海洋研究所 | 抗生素Indimicins A–E及其制备方法和在制备抗肿瘤药物中的应用 |
US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
CA3106239A1 (en) | 2018-07-27 | 2020-01-30 | Biotheryx, Inc. | Bifunctional compounds as cdk modulators |
RU2726801C1 (ru) * | 2019-10-16 | 2020-07-15 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) | Средство для терапии опухолей |
WO2021222150A2 (en) | 2020-04-28 | 2021-11-04 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015578A (en) * | 1989-03-23 | 1991-05-14 | Bristol-Myers Squibb Company | BMY-41950 antitumor antibiotic |
JPH05140168A (ja) * | 1991-11-13 | 1993-06-08 | Asahi Chem Ind Co Ltd | インドロカルバゾール誘導体及び該化合物を有効成分とする抗腫瘍剤 |
NZ245203A (en) * | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
JPH07112987A (ja) * | 1993-10-14 | 1995-05-02 | Asahi Chem Ind Co Ltd | スタウロスポリン糖部分変換誘導体 |
CO4940430A1 (es) * | 1997-07-07 | 2000-07-24 | Novartis Ag | Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales |
-
1999
- 1999-11-17 FR FR9914433A patent/FR2801054B1/fr not_active Expired - Fee Related
-
2000
- 2000-11-07 MX MXPA00010899A patent/MXPA00010899A/es unknown
- 2000-11-09 SI SI200030082T patent/SI1101770T1/xx unknown
- 2000-11-09 PT PT00403107T patent/PT1101770E/pt unknown
- 2000-11-09 DE DE60002142T patent/DE60002142T2/de not_active Expired - Fee Related
- 2000-11-09 EP EP00403107A patent/EP1101770B1/fr not_active Expired - Lifetime
- 2000-11-09 ES ES00403107T patent/ES2197061T3/es not_active Expired - Lifetime
- 2000-11-09 DK DK00403107T patent/DK1101770T3/da active
- 2000-11-09 AT AT00403107T patent/ATE237625T1/de not_active IP Right Cessation
- 2000-11-14 JP JP2000346837A patent/JP3602050B2/ja not_active Expired - Fee Related
- 2000-11-15 PL PL00343879A patent/PL343879A1/xx not_active Application Discontinuation
- 2000-11-16 NZ NZ508231A patent/NZ508231A/en unknown
- 2000-11-16 EA EA200001078A patent/EA004737B1/ru unknown
- 2000-11-16 NO NO20005796A patent/NO20005796L/no not_active Application Discontinuation
- 2000-11-17 CN CNB001285416A patent/CN1152040C/zh not_active Expired - Fee Related
- 2000-11-17 AU AU71681/00A patent/AU771584B2/en not_active Ceased
- 2000-11-17 CA CA002325779A patent/CA2325779C/fr not_active Expired - Fee Related
- 2000-11-17 KR KR10-2000-0068432A patent/KR100453980B1/ko not_active IP Right Cessation
- 2000-11-17 HU HU0004574A patent/HUP0004574A3/hu unknown
- 2000-11-17 ZA ZA200006729A patent/ZA200006729B/xx unknown
- 2000-11-17 BR BR0005426-7A patent/BR0005426A/pt not_active Application Discontinuation
-
2001
- 2001-11-05 US US10/010,379 patent/US6569858B2/en not_active Expired - Fee Related
- 2001-11-08 HK HK01107825A patent/HK1036991A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200001078A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ 12,13-(ПИРАНОЗИЛ)-ИНДОЛО[2,3-α]ПИРРОЛО[3,4-С]КАРБАЗОЛА И 12,13-(ПИРАНОЗИЛ)-ФУРО[3,4-C]ИНДОЛО[2,3-α]КАРБАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ | |
MXPA05007516A (es) | Derivados de hexahidropirazino[1,2-a]pirimidina -4, 7-diona sustituidos, metodo para producirlos y su uso como medicamentos. | |
MY132073A (en) | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents | |
WO2003022216A3 (en) | Biaryl substituted purine derivatives as potent antiproliferative agents | |
SI1730144T1 (sl) | Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on | |
EP1193256A8 (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins | |
DE69429570D1 (de) | Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente | |
AR036176A1 (es) | Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado | |
GEP20063972B (en) | Streptogramin derivatives, preparation and compositions containing them | |
TW334425B (en) | Annelated dihydropyridines for preparing pharmaceutical preparations | |
ATE244221T1 (de) | Pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
EA200200663A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ ОКТАГИДРО-2H-ПИРИДО[1,2-α]ПИРАЗИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, ИХ СОДЕРЖАЩИЕ | |
EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их | |
DE69710909D1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
ES2155948T3 (es) | 20-oxopregna-derivados 17-cadena lateral alquinilica de la vitamina d, metodos para su produccion y composiciones farmaceuticas de los mismos. | |
EA200501232A1 (ru) | Новые трициклические соединения азепина, способ их получения и содержащие их фармацевтические композиции | |
FR2616663B1 (fr) | Nouveaux tripeptides a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ATE146476T1 (de) | Cephalosporinverbindungen und verfahren zu ihrer herstellung | |
UA40567C2 (ru) | Производные фосфолипидов, способ получения производных фосфолипидов, фармацевтическая композиция и способ ее получения | |
EA200500572A1 (ru) | Новые соединения пирроло[3,4-c]карбазола и пиридо[2,3-b]пирроло[3,4-e]индола, способ их получения и фармацевтические композиции, которые их содержат | |
KR910020018A (ko) | 피리도[3, 4-b] 피롤로[1, 2-e][1, 4, 5]옥사디아제핀 및 이의 관련 동족체 이의 제조방법 및 약제로서의 이의 용도 | |
GEP20063900B (en) | Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same | |
BR9802850A (pt) | Compostos bis-pirido [4-3-b] carbazol, processo para sua preparação e composições farmacêuticas contendo-as. | |
ECSP982737A (es) | Derivados de la tienopirimidina y de la tienopiridina como agentes anticancerigenos | |
ITMI932377A1 (it) | Composizioni terapeutiche ad attivita' antitumorale a base di derivati 1,3,8,10 tetrasostituiti del 4,5,6,7-tetratiocino-(1,2-b: 3,4-b')- |